Espectively, with biopsyproven acute rejection in 26.four , DGF in 50 , and CIT of
Espectively, with biopsyproven acute rejection in 26.four , DGF in 50 , and CIT of five.6 three.2 h. In our study, over a imply followup of 21.84 16.39 months, 1year…
Espectively, with biopsyproven acute rejection in 26.four , DGF in 50 , and CIT of five.6 three.2 h. In our study, over a imply followup of 21.84 16.39 months, 1year…